Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma clinical trials

Explore recruiting relapsed refractory cd7 t cell acute lymphoblastic leukemia lymphoma clinical trials.

Recruiting relapsed refractory cd7 t cell acute lymphoblastic leukemia lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II study of anti-CD7 Chimeric Antigen Receptor-Expressing T cells in pediatric patients/young adult affected by relapsed/refractory CD7+ T-cell Acute Lymphoblastic Leukemia/Lymphoma

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma trials by city

Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Toronto Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Vancouver Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Montreal Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Calgary Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Edmonton Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Ottawa Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Winnipeg Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Quebec City Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Hamilton Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Kitchener Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in London Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Halifax Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in New York Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Los Angeles Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Chicago Relapsed Refractory Cd7 T Cell Acute Lymphoblastic Leukemia Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease